The Biologic Therapy Access Working Group is a network of policy-minded health care providers who advocate for patient-centered care. By participating in advocacy initiatives and the development of educational resources, working group members ensure that the clinician’s perspective informs policy discussions on biologics and biosimilars. To learn more, or to join AfPA’s Biologic Therapy Access Working Group, please email [email protected].